RIPE-KG · Version 1.1.0 · Resource

ripekg:study-design-evidence/RIPEA3A616563C128D80E

https://w3id.org/ripe/ripe-kg/study-design-evidence/RIPEA3A616563C128D80E
SubjectPredicateObject
ripekg:evaluation/RIPEA3A616563C128D80E prov:used ripekg:study-design-evidence/RIPEA3A616563C128D80E
ripekg:study-design-evidence/RIPEA3A616563C128D80E rdf:type rdfs:Resource
ripekg:study-design-evidence/RIPEA3A616563C128D80E rdf:type owl:Thing
ripekg:study-design-evidence/RIPEA3A616563C128D80E rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:study-design-evidence/RIPEA3A616563C128D80E rdf:type ripe:StudyDesignEvidenceStudy design evidence
ripekg:study-design-evidence/RIPEA3A616563C128D80E rdf:type tido:Evidence
ripekg:study-design-evidence/RIPEA3A616563C128D80E prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA3A616563C128D80E
ripekg:study-design-evidence/RIPEA3A616563C128D80E prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA3A616563C128D80E
ripekg:study-design-evidence/RIPEA3A616563C128D80E ripe:concerns ripekg:work/10.1002%2Fptr.6406Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial
ripekg:study-design-evidence/RIPEA3A616563C128D80E ripe:recruitmentEndDateExtractionRationale No explicit recruitment_finish date found after a full search.
ripekg:study-design-evidence/RIPEA3A616563C128D80E ripe:recruitmentStartDate 06-2017
ripekg:study-design-evidence/RIPEA3A616563C128D80E ripe:recruitmentStartDateExtractionRationale Results: 'From June 2017' indicates the start of recruitment; no specific day is mentioned.
ripekg:study-design-evidence/RIPEA3A616563C128D80E ripe:studyEndDate 02-2018
ripekg:study-design-evidence/RIPEA3A616563C128D80E ripe:studyEndDateExtractionRationale Results: 'to February 2018' indicates the end of the study; no specific day is mentioned.
ripekg:study-design-evidence/RIPEA3A616563C128D80E tido:supports ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-human-2-2
ripekg:study-design-evidence/RIPEA3A616563C128D80E tido:supports ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-inspectai-2-2